Last reviewed · How we verify

NCT03923348

Pelvic Floor Muscle Training With Leva System for Urge Incontinence

Terminated NA Last updated 1 July 2020
What this trial tests

NA trial testing Leva device in Overactive Bladder in 5 participants. Terminated before completion.

Timeline
6 June 2019
Primary endpoint
4 May 2020
4 May 2020

Quick facts

Lead sponsorThe Christ Hospital
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment5
Start date6 June 2019
Primary completion4 May 2020
Estimated completion4 May 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

The Christ Hospital

Who can join

Adults 18 to 85, female only, with Overactive Bladder or Urge Urinary Incontinence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a pilot non-comparative study to assess the effectiveness of pelvic floor muscle training guided by the leva® system for improving change in subject-reported incontinence-related quality of life and urgency urinary incontinence (UUI) episode frequency based on voiding diaries in women at 8 weeks.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Overactive Bladder

Currently open trials in the same condition.

Other The Christ Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03923348.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing